Combinatorial chemistry in cancer research

被引:6
作者
Messeguer, A. [1 ]
Cortes, N. [1 ]
机构
[1] CSIC, Inst Invest Quim & Ambientals Barcelona, Dept Biol Organ Chem, ES-08034 Barcelona, Spain
关键词
cancer; drug discovery; combinatorial chemistry; chemical libraries; lead compounds;
D O I
10.1007/s12094-007-0017-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Among the different strategies to treat cancer, chemotherapy approaches are the subject of intense research efforts. There is still a high demand for new anticancer drugs exhibiting improved efficiency and selectivity for their use in combined therapy strategies. The high development of molecular and cellular biology tools has made possible the set up of simple in vitro assays, susceptible to automation, thus bringing about the possibility of rapid screening of hundreds of compounds. Chemistry has reacted to this challenge by developing a new technology: combinatorial chemistry. By this procedure large collections of compounds, known as chemical libraries, can be prepared in a rapid and efficient manner. In recent years, combinatorial chemistry has had a great impact on drug discovery programmes addressed to tackling cancer pharmaceutical targets. In this review, the contribution of this technology to the discovery of anticancer drugs that are currently in clinical trials or already in the market is discussed.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 82 条
[1]   Trimers of N-alkylglycines are potent modulators of the multidrug resistance phenotype [J].
Abad-Merin, MJ ;
Cortés, N ;
Masip, I ;
Pérez-Payá, E ;
Ferragut, JA ;
Messeguer, A ;
Ferrer-Montiel, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01) :112-120
[2]   Combinatorial library of serine and cysteine protease inhibitors that interact with both the S and S′ binding sites [J].
Abate, P ;
Conroy, JL ;
Seto, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (19) :4001-4009
[3]   Finding the needle in the haystack: why high-throughput screening is good for your health [J].
Aherne, GW ;
McDonald, E ;
Workman, P .
BREAST CANCER RESEARCH, 2002, 4 (04) :148-154
[4]   A convenient procedure for the solution phase preparation of 2-aminothiazole combinatorial libraries [J].
Bailey, N ;
Dean, AW ;
Judd, DB ;
Middlemiss, D ;
Storer, R ;
Watson, SP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (12) :1409-1414
[5]  
Balkenhohl F, 1996, ANGEW CHEM INT EDIT, V35, P2289
[6]   TRANSLOCATION OF C-ABL ONCOGENE CORRELATES WITH THE PRESENCE OF A PHILADELPHIA-CHROMOSOME IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
BARTRAM, CR ;
DEKLEIN, A ;
HAGEMEIJER, A ;
VANAGTHOVEN, T ;
VANKESSEL, AG ;
BOOTSMA, D ;
GROSVELD, G ;
FERGUSONSMITH, MA ;
DAVIES, T ;
STONE, M ;
HEISTERKAMP, N ;
STEPHENSON, JR ;
GROFFEN, J .
NATURE, 1983, 306 (5940) :277-280
[7]   P-glycoproteins and multidrug resistance [J].
Bellamy, WT .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :161-183
[8]   Synthesis and evaluation of paclitaxel C7 derivatives: Solution phase synthesis of combinatorial libraries [J].
Bhat, L ;
Liu, YB ;
Victory, SF ;
Himes, RH ;
Georg, GI .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) :3181-3186
[9]   Combinatorial approaches in anticancer drug discovery: Recent advances in design and synthesis [J].
Bhattacharyya, S .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (12) :1383-1404
[10]   Multistep convergent solution-phase combinatorial synthesis and deletion synthesis deconvolution [J].
Boger, DL ;
Chai, WY ;
Jin, Q .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (29) :7220-7225